Coexistence of oxidized lipids and α-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 7, 1999, Pages 1708-1718

  Niu, Xianwa ^a   Zammit, Vivienne ^a   Upston, Joanne M ^a   Dean, Roger T ^a   Stocker, Roland ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Antioxidants; Atherosclerosis; Lipid peroxidation; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; FEMALE; HUMAN; LIPID COMPOSITION; LIPID OXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; VITAMIN INTAKE;

EID: 0033031276     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.7.1708     Document Type: Article

References (56)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
2. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
3. Steinbrecher UP, Lougheed M. Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. Arterioscler Thromb. 1992;12:608-625.
4. Hoff HF, O'Neil J, Pepin JM, Cole TB. Macrophage uptake of cholesterol-containing particles derived from LDL and isolated from atherosclerotic lesions. Eur Heart J. 1990;11:(suppl E):105-115.
5. Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest. 1996;97:1535-1544.
6. Hazen SL, Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest. 1997;99:2075-2081.
7. Suarna C, Dean RT, May J, Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol. 1995;15:1616-1624.
8. Stocker R, Frei B. Endogenous antioxidant defenses in human blood plasma. In: Sies H, ed. Oxidative Stress: Oxidants and Antioxidants. London, UK: Academic Press; 1991:213-243.
9. Cleary J, Mohr D, Adams MR, Celermajer DS, Stocker R. Plasma, and LDL levels of major lipophilic antioxidants are similar in patients with advanced atherosclerosis and healthy controls. Free Radic Res. 1997;26: 175-182.
10. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A. 1989;86:6377-6381.
11. Burton GW, Joyce A, Ingold KU. Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes? Arch Biochem Biophys. 1983;221:281-290.
12. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A. 1988;85:9748-9752.
13. Dabbagh AJ, Frei B. Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophages and in cell-free systems. J Clin Invest. 1995;96:1958-1966.
14. Mohr D, Umeda Y, Redgrave TG, Stocker R. Antioxidant defenses in rat intestine and mesenteric lymph. Redox Report 1998. In press.
15. Suarna C, Dean RT, Southwell-Keely P, Moore DE, Stocker R. Separation and characterization of cholesteryl oxo-and hydroxy-linoleate in human atherosclerotic plaque. Free Radic Res. 1997;27:397-408.
16. Ylä-Herttuala S, Jaakkola Q, Ehnholm C, Tikkanen MJ, Solakivi T, Sarkioja T, Nikkari T. Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. J Lipid Res. 1988;29:563-572.
17. Liebler DC, Burr JA, Philips L, Ham AJ. Gas chromatography-mass spectrometry analysis of vitamin E and its oxidation products. Anal Biochem. 1996;236:27-34.
18. Sattler W, Mohr D, Stocker R. Rapid isolation of lipoproteins and assessment of their peroxidation by HPLC postcolumn chemiluminescence. Methods Enzymol. 1994;233:469-489.
19. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Steinberg D, Witztum JL. Lipoproteins in normal and atherosclerotic aorta. Eur Heart J. 1990;11: (suppl E):88-99.
20. Kritharides L, Jessup W, Gifford J, Dean RT. A method for defining the stages of LDL oxidation by the separation of cholesterol and cholesteryl ester-oxidation products by HPLC. Anal Biochem. 1993;213:79-89.
21. Pascoe GA, Duda CT, Reed DJ. Determination of α-tocopherol and α-tocopherylquinone in small biological samples by high-performance liquid chromatography with electrochemical detection. J Chromatogr. 1987;414:440-448.
22. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82: 70-77.
23. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull WJ, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol. 1995;15:1512-1531.
24. Smith EB, Slater RS. The chemical and immunological assay of low density lipoprotein extracted from human aortic intima. Atherosclerosis. 1970;11:417-438.
25. Daugherty A, Zweifel BS, Sobel BE, Schonfeld G. Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis. 1988;8:768-777.
26. Suama C, Hood RL, Dean RT, Stocker R. Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat and human lipoproteins. Biochim Biophys Acta. 1993;1166:163-170.
27. Hoff HF, O'Neil J. Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. Arterioscler Thromb. 1991;11: 1209-1222.
28. Khoo JC, Miller E, McLoughlin P, Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis. 1988;8:348-358.
29. Hoff HF, O'Neil J, Cole TB. Macrophage degradation of LDL extracted from human aortic plaques: effect of isolation conditions. Exp Mol Pathol. 1991;54:72-86.
30. Heideman CL, Hoff HF. Lipoproteins containing apolipoprotein A-I extracted from human aortas. Biochim Biophys Acta. 1982;711:431-444.
31. Hoff HF, Gaubatz JW. Isolation, purification, and characterization of a lipoprotein containing apo B from human aorta. Atherosclerosis. 1982; 42:273-297.
32. Schissel SL, Tweedie-Hardman J, Rapp JH, Graham G, Williams KJ, Tabas I. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. J Clin Invest. 1996; 98:1455-1464.
33. Frank H, Thiel D, McLeod J. Mass spectrometric detection of cross-linked fatty acids formed during radical-induced lesion of lipid membranes. Biochem J. 1989;260:873-878.
34. Hollander W, Paddock J, Colombo M. Lipoproteins in human atherosclerotic vessels. I. Biochemical properties of arterial low density lipoproteins, very low density lipoproteins, and high density lipoproteins. Exp Mol Pathol. 1979;30:144-171.
35. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res. 1996;37:693-707.
36. Esterbauer H, Jürgens G, Quehenberger O, Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res. 1987;28:495-509.
37. Esterbauer H, Gebicki J, Puhl H, Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992;13:341-390.
38. Bowry VW, Stocker R. Tocopherol-mediated peroxidation: the prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc. 1993;115:6029-6044.
39. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease: a critical review of epidemiologic and clinical trial data. Ann Intern Med. 1995;123:860-872.
40. Carpenter KL, Cheeseman KH, van der Veen C, Taylor SE, Walker MK, Mitchinson MJ. Depletion of alpha-tocopherol in human atherosclerotic lesions. Free Radic Res. 1995;23:549-558.
41. Barclay LRC, Baskin KA, Kong S, Locke SJ. Autoxidation of model membranes. The kinetics and mechanism of autoxidation of mixed phospholipid bilayers. Can J Chem. 1987;65:2541-2550.
42. Barclay LR, Cameron RC, Forrest BJ, Locke SJ, Nigam R, Vinqvist MR. Cholesterol: free radical peroxidation and transfer into phospholipid membranes. Biochim Biophys Acta. 1990;1047:255-263.
43. Carpenter KLH, Taylor SE, Ballantine JA, Fussell B, Halliwell B, Mitchinson MJ. Lipids and oxidised lipids in human atheroma and normal aorta. Biochim Biophys Acta. 1993;1167:121-130.
44. Brown AJ, Leong S, Dean RT, Jessup W. 7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque. J Lipid Res. 1997;38:1730-1745.
45. Smith EB. The relationship between plasma and tissue lipids in human atherosclerosis. Adv Lipid Res. 1974;12:1-49.
46. Bowry VW, Stanley KK, Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in fasted human plasma. Proc Natl Acad Sci U S A. 1992;89:10316-10320.
47. Mohr D, Stocker R. Radical-mediated oxidation of isolated human very low density lipoprotein. Arterioscler Thromb. 1994;14:1186-1192.
48. Christison J, Rye K-A, Stocker. Exchange of oxidised cholesteryllinoleate between LDL and HDL mediated by cholesteryl ester transfer protein. J Lipid Res. 1995;36:2017-2026.
49. Schwenke DC, Carew TE. Initiation of atherosclerotic lesion in cholesterol-fed rabbits, II. Selective retention of LDL vs selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis. 1989; 9:908-918.
50. Ingold KU, Bowry VW, Stocker R, Walling C. Autoxidation of lipids and antioxidation by α-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: the unrecognized consequences of lipid particle size as exemplified by the oxidation of human low density lipoprotein. Proc Natl Acad Sci U S A. 1993;90:45-49.
51. Witting PK, Upston JM, Stocker R. The molecular action of α-tocopherol in lipoprotein lipid peroxidation: pro-and antioxidant activity of vitamin E in complex heterogeneous lipid emulsions. In: Quinn P, Kagan V, eds. Subcellular Biochemistry: Fat-Soluble Vitamins. London, UK: Plenum; 1998:345-390.
52. Porter NA, Lehman LS, Weber BA, Smith KJ. Unified mechanism for polyunsaturated fatty acid autoxidation: competition of peroxy radical hydrogen atom abstraction, β-scission, and cyclization. J Am Chem Soc. 1981;103:6447-6455.
53. Kenar JA, Havrilla CM, Porter NA, Guyton JR, Brown SA, Klemp KF, Selinger E. Identification and quantification of the regioisomeric cholesteryl linoleate hydroperoxides in oxidized human low density lipoprotein and high density lipoprotein. Chem Res Toxicol. 1996;9: 737-744.
54. Thomas SR, Neuzil J, Stocker R. Co-supplementation with coenzyme Q prevents the pro-oxidant effect of α-tocopherol and increases the resistance of low-density lipoprotein towards transition metaldependent oxidation initiation. Arterioscler Thromb Vasc Biol. 1996; 16:687-696.
55. Neuzil J, Christison JK, Iheanacho E, Fragonas J-C, Zammit V, Hunt NH, Stocker R. Radical-induced lipoprotein and plasma lipid oxidation in normal and apolipoprotein E gene knockout (apoE-/-) mice: apoE-/-mouse as a model for testing the role of tocopherol-mediated peroxidation in atherogenesis. J Lipid Res. 1998;39:354-368.
56. Upston JM, Terentis AC, Stocker R. Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J. In press.